A library of 1H-pyrrolo[3,2-c]quinolines (PQs) was synthesized, and SAR analysis identified compounds with low-nanomolar potency in CCRF-CEM cells (IC50 = 13−18 nM) and selectivity indices > 1000-fold over BJ fibroblasts. The most active derivatives retained activity against daunorubicin-resistant and paclitaxel-resi...
P. Králová, Jiří Řehulka, K. Grychowska et al.· Journal of Medicinal Chemist...· 0 citations
Several final compounds showed potent in vitro cytotoxic activity on a small panel of cancer cell lines, but with no selectivity against nonmalignant fibroblasts BJ and MRC‐5.
Ugnė Šinkevičiūtė, Kateřina Burgetová Ječmeňová, S. Gurská et al.· ChemMedChem· 0 citations
Results suggest that the N-(4-(chlorodifluoromethoxy)phenyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxamide scaffold is a useful template for designing selective BCR-ABL1-directed anticancer agents, with compound 9c as an encouraging lead for further optimisation and mechanistic studies.
Pradeep B. Bhise, Sandeep B. Bhise, Somnath Dasgupta et al.· RSC Advances· 0 citations
Both in vitro and computational analyses demonstrated that compounds 11, 12, and 13 exhibit high affinity for the A Cα subunit of protein kinase A, suggesting a kinase‐targeted mechanism of action, providing a structural foundation for future design strategies to optimize the potency of these lead compounds.
A. Suárez, Katiuska Chávez, Pablo Martínez et al.· ChemMedChem· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.